InoLife Engages Chief Financial Officer
(firmenpresse) - RALEIGH, NC -- (Marketwired) -- 09/05/13 -- InoLife Technologies, Inc. (OTCQB: INOL), a diversified service based healthcare and environmental product developer and marketer is pleased to announce the Company has hired Mr. James W. Thomas II as Chief Financial Officer.
With strong expansion and development plans in place for 2013-2014, the Company has recruited Mr. Thomas to serve as a senior member of the management team to lead the areas of accounting and finance. The Company's CEO, Mr. Gary Berthold, states, "The addition of Mr. Thomas to the management team is important and is in keeping with its execution of the growth strategy. Mr. Thomas brings more than 30 years of experience in accounting and financial solutions to the public and private companies."
In addition, Mr. Thomas is an accounting and finance professional experience including previous Securities and Exchange Commission reporting. Mr. Thomas is the president of a Financial Services company supporting small, medium and public businesses. Mr. Thomas also served as the president of a food manufacturing company. Mr. Thomas is a specialist in implementing and integrating ERP systems from multiple companies.
Mr. Thomas will be responsible for all accounting aspects including internal/external financial management, financial reporting, quarterly SEC filings, budgets, forecasting, cost accounting, and audit management.
InoLife Technologies, Inc. is organized to develop and market DNA Testing products within the US. The Company's mission is to aggressively identify, manufacture and market innovative and affordable healthcare products and services directly to the marketplace. By targeting cutting-edge DNA-based testing and reporting methodologies, the company is able to significantly benefit the health and wellness needs of both individuals and their healthcare providers.
InoLife Technologies, Inc. markets the commercial use of proprietary Intellectual Property by manufacturing, brand marketing and selling an integrated program of age reversing creams and lotions. These products will be sold directly to consumers through e-commerce, direct sales, pharmacies, retailers, distributors and healthcare providers. It also offers products that are sold only to physicians, hospitals, outpatient facilities and others in the medical community for use with their patients.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements including, but not limited to, certain delays beyond the Company's control with respect to market acceptance of new technologies, products and services, delays in testing and evaluation of products and services, and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission.
Investor Information Contact:
Henry Harrison
407-350-0146
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 05.09.2013 - 06:32 Uhr
Sprache: Deutsch
News-ID 1260785
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
RALEIGH, NC
Phone:
Kategorie:
Surgery & Treatments
Anmerkungen:
Diese Pressemitteilung wurde bisher 206 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"InoLife Engages Chief Financial Officer
"
steht unter der journalistisch-redaktionellen Verantwortung von
InoLife Technologies, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
